Latest News
Pet owners’ love for their animals, along with the impact of Covid-19, are among the reasons private equity decision-makers feel bullish about the future of the animal care sector, according to a new survey of 100 industry leaders conducted by Katten.
Thompson Street Capital Partners (TSCP), a private equity firm based in St Louis, has completed the sale of Analytical Lab Group (ALG), a microbiology and viral lab, to Element Materials Technology (Element), one of the world’s largest providers of materials and product qualification testing, inspection and certification services to the global aerospace, transportation & industrials, connected technologies, energy, and fire & building products sectors.ALG’s team of 130 scientists and experts operates a number of FDA and EPA compliance focused laboratories in San Francisco, Minneapolis and Boston and has built a strong reputation in the infection prevention market, offering comprehensive testing
Eurazeo has completed a EUR80 million investment from its China Acceleration Fund in DORC (Dutch Ophthalmic Research Center), a specialist in the area of vitreoretinal surgery.
AnaCap Financial Partners (AnaCap), a specialist European financial services private equity firm, has promoted Edward Green, Nassim Cherchali and Tassilo Arnhold to Partner, further strengthening its senior team. As part of this promotion, the individuals will also be appointed to AnaCap’s investment committees as voting members for private equity and credit respectively.
Green joined AnaCap in 2007 as part of our Business Services team within private equity, leading operational engagement across various portfolio companies. His involvement helped Cabot Credit Management becoming a leading UK consumer debt purchasing company and First Names Group developing into a top, global corporate trust and services provider.
EMQ, an Asian financial settlement network, has issued USD20 million of Series B Preferred Shares, led by WI Harper Group, with participation from new and existing investors including Abu Dhabi Capital, AppWorks, DG Ventures, Hard Yaka, Intudo Ventures, January Capital, Quest Venture Partners, SparkLabs Taipei, Vectr Fintech Partners, and VS Partners. EMQ will use the investment to further accelerate its international growth, product development and licensing activities across Asia, Europe and the Americas.
“At EMQ, we are building a global settlement network that enables everyone to send money anywhere in the world and to any end point with a simple one-stop
Investors have rewarded the commercial success of Spotta’s smart pest systems with a USD1.18 million seed funding round. This investment reflects Spotta’s huge potential in global markets in farming, forestry, hospitality, and other sectors to solve the GBP320 billion (USD400 billion) problem of insect pests while dramatically reducing pesticide use.
Representatives of Cambridge Angels and REMUS, a US-based VC firm, will join Spotta’s board as part of the GBP934,000 (USD1,184,287) investment deal. Other major investors include Martlet Capital, Wren Capital, and the Angel CoFund.
Based in Cambridge, Spotta commercialised its first product in 2019 and has been recognised by
Advent France Biotechnology and Invivo Ventures have invested EUR4.25 million into Valencia-based Arthex Biotech, a pre-clinical stage life sciences company focused on the development of next generation antisense RNA therapies.
The latest round follows on from an initial seed round of EUR2.7 million by Invivo and CDTI-Innvierte in December 2019, and in June 2020 respectively. The total amount raised by Arthex since inception now stands at EUR6.95 million. The fresh capital will enable Arthex to complete its first-in-human trial by 2022.
“Arthex Biotech represents a unique combination of world-class science and entrepreneurial skills, translating great discoveries into potential breakthrough therapeutic
Trainor, a provider of electrical safety training, digital solutions and consultancy services to the global energy, renewables, power and grid, and maritime industries, has secured new investment from EV Private Equity to support its ambitious international expansion plans. The investment will see EV Private Equity become the majority shareholder, alongside Trainor management and employees.
This investment will fund the business´ expansion across the Nordics. The existing high-calibre management team will be strengthened and augmented in the sales and financials functions. EV Private Equity’s Senior Partners Per Arne Jensen and Rune Jensen, and Investment Director, Tomas Hvamb, will join the Board
New digital deal platform dubbed Maksab has officially launched with the aim of helping corporate advisers and consultants serve and assist SMEs with streamlined deal-making through exclusive emerging transactions and efficient management features. Maksab connects advisors and private professional investors with SMEs that are seeking growth capital in a virtual environment. The platform is developed for corporate finance consultants and transaction agents known as (advisers), SME business owners (sell-side) and private investors (buy-side).
The Maksab Platform leverages the Ethereum blockchain to allow confidential, secure, streamlined, efficient and reliable transactions between platform users by deploying Ethereum-based ERC-20 smart contract. The smart contract
Fund+, an investment firm focused on European Life Sciences companies, has led a EUR38 million Series B financing in new portfolio company, Indigo Diabetes (Indigo). Indigo is developing a novel ‘invisible’ continuous glucose monitoring device for diabetics. Jan Van den Bossche, Partner at Fund+, will join the Board.
Indigo has developed a small chip using nano-photonics that is designed to measure glucose and ketones in people with diabetes. The product is ‘invisible’ as it is inserted subcutaneously in the patient’s skin and cannot be seen. It has the potential to continuously monitor glucose levels for up to two years enabling
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
